Litigation Details for AstraZeneca AB v. Aurobindo Pharma USA Inc. (D. Del. 2019)
✉ Email this page to a colleague
AstraZeneca AB v. Aurobindo Pharma USA Inc. (D. Del. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-11-07 |
Court | District Court, D. Delaware | Date Terminated | 2021-09-22 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 9,012,469 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in AstraZeneca AB v. Aurobindo Pharma USA Inc.
Details for AstraZeneca AB v. Aurobindo Pharma USA Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-11-07 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (kmd) (Entered: 11… 22 September 2021 1:19-cv-02113 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2021-09-22 | 69 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (Attachments: # 1 … 22 September 2021 1:19-cv-02113 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |